Auour Investments’s Tyra Biosciences TYRA Stock Holding History

Auour Investments’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$805K	Hold	21,020	–	–	0.25%	46
2025 Q4	$553K	Hold	21,020	–	–	0.18%	54
2025 Q3	$294K	Hold	21,020	–	–	0.1%	65
2025 Q2	$201K	Hold	21,020	–	–	0.07%	81
2025 Q1	$217K	Hold	21,020	–	–	0.08%	73
2024 Q4	$304K	Hold	21,020	–	–	0.11%	66
2024 Q3	$355K	Sell	21,020 -64,000	-75%	-$1.34M	0.13%	63
2024 Q2	$1.36M	Hold	85,020	–	–	0.51%	38
2024 Q1	$1.39M	Hold	85,020	–	–	0.51%	39
2023 Q4	$1.14M	Hold	85,020	–	–	0.45%	38
2023 Q3	$1.2M	Hold	85,020	–	–	0.51%	38
2023 Q2	$1.45M	Buy	+85,020	New	+$1.23M	0.61%	34

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Auour Investments's TYRA Position: Q1 2026 in Review

Auour Investments held its Tyra Biosciences (TYRA) position steady in Q1 2026 at 21,020 shares worth $805K. The position accounts for 0.25% of the portfolio, ranked #46.

Auour Investments first reported a position in TYRA in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.45M in Q2 2023. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

Auour Investments held 21,020 shares of Tyra Biosciences worth $805K as of Q1 2026.
Auour Investments left its Tyra Biosciences share count unchanged in Q1 2026.
Tyra Biosciences made up 0.25% of Auour Investments's portfolio in Q1 2026, its #46 holding.
Auour Investments first reported a position in Tyra Biosciences in Q2 2023 and has held it in 12 quarters since.
Auour Investments's Tyra Biosciences position peaked at $1.45M in Q2 2023.
164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Auour Investments's 13F filing for Q1 2026, filed 20 Apr 2026.